Viewing Study NCT02413008


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-03 @ 3:15 PM
Study NCT ID: NCT02413008
Status: COMPLETED
Last Update Posted: 2019-08-05
First Post: 2015-04-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Sponsor: ITF Research Pharma, S.L.U.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10-16
Start Date Type: ACTUAL
Primary Completion Date: 2017-02-10
Primary Completion Date Type: ACTUAL
Completion Date: 2017-02-10
Completion Date Type: ACTUAL
First Submit Date: 2015-04-01
First Submit QC Date: None
Study First Post Date: 2015-04-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-08-08
Results First Submit QC Date: None
Results First Post Date: 2019-08-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-06-21
Last Update Post Date: 2019-08-05
Last Update Post Date Type: ACTUAL